Polymeric delivery of proteins and plasmid DNA for tissue engineering and gene therapy

Critical Reviews in Eukaryotic Gene Expression

Volumn 11, Issue 1-3, 2001, Pages 47-58

  Richardson, Thomas P ^a   Murphy, William L ^a   Mooney, David J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Biological response; Controlled release; Growth factors; Plasmid DNA; PLGA; Protein stability

Indexed keywords

DRUG VEHICLE; GROWTH FACTOR; PLASMID DNA; POLYGLACTIN; POLYGLYCOLIC ACID; POLYMER; PROTEIN;

CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; PROTEIN TARGETING; REVIEW;

EID: 0034782511     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: 10.1615/critreveukargeneexpr.v11.i1-3.30     Document Type: Review

References (60)

1. PLGA micropsheres containing plasmid DNA: Preservation of supercoiled DNA via cryopreservation and carbohydrate stabilization
2. Efficient gene delivery by a peptide derived from a monoclonal anti-DNA antibody
3. Materials for protein delivery in tissue engineering
4. Poly(lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo
5. Gene therapy for tissue repair and regeneration
6. Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration
7. Mechanism of epidermal growth factor receptor autophosphorylation and highaffinity binding
8. Synthesis of cross-linked poly(aldehyde guluronate) hydrogels
9. Stable formulations of recombinant human growth hormone and interferongamma for microencapsulation in biodegradable microspheres
10. The stability of recombinant human growth hormone on poly(lactic-co-glycolic acid) (PLGA) microspheres
11. Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres
12. Biodistribution, metabolism, and in vivo gene expression of low molecular weight glycopeptide polyethylene glycol DNA co-condensates
13. Effect of excipients on the stability and structure of lyophilized recombinant human growth hormone
14. Water sorption behavior or lyophilized protein-sugar systems and implications for solid-state interactions
15. High-efficiency gene transfer employing adenovirus-polylysine-DNA complexes
16. A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within basement membrane
17. A new absorbable suture
18. Protein stability in controlled-release systems
19. Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres
20. Biodegradable polymers for protein and peptide drug delivery
21. Protein release from alginate matrices
22. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin
23. Controlled release of interleukin-2 from biodegradable microspheres
24. Release of human serum albumin from poly(lactide-co-glycolide) microspheres
25. Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer
26. The stabilization and encapsulation of human growth hormone into biodegradable microspheres
27. Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation and development
28. Mechanisms of solute release from porous hydrophilic polymers
29. Stabilization of nerve growth factor in controlled release polymers and in tissue
30. Novel systems for controlled delivery of macromolecules
31. Stabilization of poly-L-lysine/DNA polyplexes for in vivo gene delivery to the liver
32. New methods of drug delivery
33. Polymers for the sustained release of proteins and other macromolecules
34. The importance of new processing techniques in tissue engineering
35. Photopolymerization of multilaminated poly(HEMA) hydrogels for controlled release
36. Biophysical integration of effects of epidermal growth factor and fibronectin on fibroblast migration
37. Polyanhydride microspheres as drug carriers: I hot-melt encapsulation
38. Comparative gene transfer efficiency of low molecular weight polylysine DNA-condensing peptides
39. Latent forms of TGFbeta: Molecular structure and mechanisms of activation
40. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: Protein stabilization and in-vitro release properties
41. Growth of continuous bonelike mineral within porous poly(lactideco-glycolide) scaffolds in vitro
42. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering
43. Fibroblast growth factor-2
44. Inhibition of normal rat kidney cell growth by transforming growth factor-beta is mediated by collagen
45. Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers
46. NGF release from poly(lactic-coglycolic acid) microspheres. Effect of some formulation parameters on encapsulted NGF stability
47. Encapsulation of proteins for improved delivery
48. Regulation of basic fibroblast growth factor binding and activity by cell density and heparan sulfate
49. The influence of biodegradable microcapsule formulations on the controlled release of a protein
50. DNA delivery from polymer matrices for tissue engineering
51. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery
52. Encapsulation of rotavirus into poly(lactide-co-glycolide) microspheres
53. Incorporation of protein in PLG-microspheres with retention of bioactivity
54. Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein
55. Gene therapy-promises, problems, and prospects
56. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected cells
57. Epidermal growth factor alters fibroblast migration speed and directional persistence reciprocally and in a matrixdependent manner
58. Self-phosphorylation of epidermal growth factor receptor: Evidence for a model of intermolecular allosteric activation
59. Stabilization of proteins encapsulated in injectable poly(lactide-coglycolide)
60. Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: Mechanism of stabilization by basic additives